Search results
BIOPHEN Heparin LRT 3 (Liquid Reagent Technology)
Measuring the concentration of UFH, LMWH, Arixtra®, Orgaran®, rivaroxaban (Xarelto®), apixaban (Eliquis®) and edoxaban (Lixiana®) in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN Heparin LRT 5 (Liquid Reagent Technology)
Measuring the concentration of UFH, LMWH, Arixtra®, Orgaran®, rivaroxaban (Xarelto®), apixaban (Eliquis®) and edoxaban (Lixiana®) in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN Heparin LRT 7.5 (Liquid Reagent Technology)
Measuring the concentration of UFH, LMWH, Arixtra®, Orgaran®, rivaroxaban (Xarelto®), apixaban (Eliquis®) and edoxaban (Lixiana®) in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN Plasminogen LRT
Assay of plasminogen in human plasma for the diagnosis of congenital or acquired plasminogen deficiencies. An abnormal plasminogen activity is an indicator for fibrinolytic troubles.
BIOPHEN Protein C (LRT, Liquid Reagent Technology)
Diagnosis of congenital or acquired protein C deficiencies. Protein C concentrates.
BIOPHEN Protein C 5
Diagnosis of congenital or acquired protein C deficiencies. Protein C concentrates.
C1-Inhibitor, anti-human, goat, IgG, affinity purified
C1-Inhibitor, anti-human, goat, IgG, purified
C1-Inhibitor, anti-human, goat, IgG, purified, Peroxidase conjugated
C4b-BP, anti-human, mouse, IgG